Good Quality Pharmaceutical Raw Materials Anti-Breast Cancer Pd0332991 Palbociclib CAS 827022-32-2

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: 827022-32-2
• Application: Anti-Breast Cancer
• Product Name: Palbociclib
• Other Name: Pd0332991
• CAS No.: 827022-32-2
• Type: Pharmaceutical Intermediate
• Used for: Antitumor an Orally Active, Selective Inhibitor
• Transport Package: Bottle
• Specification: 10g; 100g; 1kg
• Trademark: SHUNYI
• Origin: China
• Production Capacity: 100kg/Month

Product Description

Good Quality Pharmaceutical Raw Materials Anti-Breast Cancer PD0332991 Palbociclib CAS 827022-32-2

Product Name: Palbociclib;PD0332991
CAS: 827022-32-2
MF:C24H30ClN7O2
MW:484
EINECS:1592732-453-0
MDL No.:MFCD22420809
storage temp. = -70C
solubility ≥14.48 mg/mL in H2O; ≥2.42 mg/mL in DMSO; ≥2.79 mg/mL in EtOH with gentle warming and ultrasonic
form Yellow liquid

COA

ITEM	SPECIFICATION	RESULT	METHOD
Appearance	White powder, neutral odor, highly hygroscopic	Conforms	Visual
Identification	Standard solution and test solution same spot,RF	Conforms	TLC
Specific Optical	-2.4°~ -2.8°	-2.72°
Heavy metals (as PB)	≤10ppm	Conforms	AAS
Sulfate (SO4)	≤0.02%	Conforms	Colorimetry
Chloride (Cl)	≤0.02%	Conforms	Colorimetry
Phosphate Ion (P)	≤5ppm	Conforms	Colorimetry
Residual solvent(ethanol)	≤1.0%	Conforms	HS-GC
pH	4.5~7.0	5.10
Related substance	Spot not bigger than standard solution spot	No spot	TLC
Water Content	≤2%	0.26%	KF
Assay (dried basis)	98.0%--102.0%	99.48%	Potentiometric titration
Assay (dried basis)	98.5%--100%	99.2%	HPLC

 Indicated for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer developed. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy by any organization.






1.Preferentially DHL, FedEX or TNT for quantity less than 50kg, air shipping for 100kg above, sea shipping for quantity over 500kg.
2.For customers from Russia,Mexico,Turkey,Solvenia,Romania,etc,before placing an order,please kindly confirm if you can make clearance when goods reach your customs.

Shipping Terms
By Express	By Air	By Sea
Suitable for under 50kg Fast:3-4 days High cost Door to door service Easy to pick up the goods	Suitable for more than 50kg Fast:3-4 days High cost Airport to airport Professional broker needed	Suitable for more than 500kg Slow:15-30 days Low cost Port to port Professional broker needed